The Biotech City is a biopharmaceutical and life sciences cluster in Greater Montreal, located near an international airport and subway network. The life sciences sector in Laval is comprised of more than 90 companies and institutions, many of which are leaders in Canada’s science economy and which employ some 5,000 people within a four-kilometre radius

1. MONTREAL-TRUDEAU
(YUL)
MONTREAL-MIRABEL
FREIGHT (YMX)
LAVAL
MONTREAL
THE
BIOTECH CITY
YOUR NORTH AMERICAN GATEWAY TO BIOSUCCESS
Boston
1h 15min
Toronto
1h 10min
New York
1h 25min
San Francisco
6h 25min
London
6h 45min
Paris
6h 50min
jobs
companies
institutes and organizations
in investments from 2001 to 2013
5 000
86
11
More than $3B
A BUSINESS AND SCIENCE CENTRE

2. PRODUCTION
C
LINICAL TRIAL
S
RENTAL SPACE
INCUBATOR
PRE-CLINICAL
DEVELOPMENT
DEVELOPMENT
PROPERTIES
RESEARCH
INSTITUTES
DISCOVERY
CENTRE NATIONAL DE BIOLOGIE EXPÉRIMENTALE (CNBE) INRS-INSTITUT ARMAND-FRAPPIER QUEBEC BIOTECHNOLOGY INNOVATION CENTRE (QBIC)
THE BIOTECH CITY
ALL DEVELOPMENT PHASES: ONE SITE

3. Montreal (QC)
Boston (MA)
Chicago (IL)
Frankfurt (GER)
London (EN)
San Diego (CA)
San Francisco (CA)
Toronto (ON)
20 40 60 80 100 120
THE QUEBEC ADVANTAGE
Operating costs among the lowest of the G8
Given its affordable labour, capital and operating
costs, Quebec is one of the most attractive locations in
the world for biopharmaceutical development, drug
manufacturing and clinical trials.
PHARMA MANUFACTURING
BIOMEDICAL R&D
CLINICAL TRIALS
Quebec’s generous tax and R&D incentives
The net cost of a $100 expenditure on R&D can be as low as $50. The
tax credit is refundable during the R&D process.
Foreign researchers and experts may qualify for a five-year provincial
income tax exemption.
At 26.9%, corporate income tax in Quebec is one of the lowest in
North America.
An innovation-based economy
Quebec offers biopharmaceutical corporations a 27.5% tax credit rate
for R&D salaries.
At the heart of the Canadian healthcare industry
Nearly half of Canada’s healthcare companies and the majority of the
country’s basic and clinical research activities are concentrated in the
Montreal region.
A highly qualified pool of talent
• 400 companies and 25,000 employees in life sciences industry
• 10,000 researchers in public biomedical research centres
• 5,000 graduates each year in biopharmaceutical-related programs
Source: Investissement Québec, September 2013
AVERAGEANNUALOPERATINGCOSTS

4. ContractResearchOrganizations(CRO)
Pharmaceutical
InformationTechnology
Biotechnology
ResearchCentres/Organizations
Consulting/Service/Distribution
MedicalDevicesandResearch
Nutraceuticalandcosmeceutical
9% 7% 12% 11% 20% 19% 5% 17%
THE BIOTECH CITY
THE DIVERSITY OF LIFE SCIENCES
The Biotech City is a biopharmaceutical and life sciences cluster in Greater Montreal, located near an international airport and
subway network. The life sciences sector in Laval is comprised of more than 90 companies and institutions, many of which are
leaders in Canada’s science economy and which employ some 5,000 people within a four-kilometre radius. The hub is made up
of companies specializing in biotechnology, pharmaceuticals, medical equipment, CROs and information technology. The Biotech
City is also home to an integrated life sciences technology park built around two research institutes, a business incubator, laboratory
facilities and development lots.
The Biotech City helps drive the life sciences industry
• Promotes networking among businesses, investors, research institutes and government agencies
• Organizes and participates in biopharmaceutical sector events
• Represents the life sciences sector on a local and international level
The Biotech City will support you in your implementation project
• Assistance in finding lots, sites and facilities
• Guidance and support through all administrative steps
• International mobility expertise
1555 Chomedey Blvd., Suite 100
Laval, Quebec H7V 3Z1 CANADA
Telephone: 450-978-5066 | Fax: 450-978-5970
info@citebiotech.com | www.citebiotech.com
Partners
A POLE OF